Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of fenretinide in treating patients who have
recurrent small cell lung cancer. Drugs used in chemotherapy use different ways to stop tumor
cells from dividing so they stop growing or die.